Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Elitra Pharmaceuticals logo — Pioneering pharmaceutical advancements since 1997, located i...

Elitra Pharmaceuticals

Pioneering pharmaceutical advancements since 1997, located in San Diego, CA.

Founded 1997 3 employees Venture round Total: $22.00M Biotechnology, Pharmaceutical

General Information

Company Name Elitra Pharmaceuticals
Founded Year 1997
Founders / Decision Makers
Team member
Employees 3
Industries Biotechnology, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Elitra Pharmaceuticals. To contact Elitra Pharmaceuticals, visit elitra.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Elitra Pharmaceuticals compare?

A PDF of Elitra Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Elitra Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Elitra Pharmaceuticals

Elitra Pharmaceuticals, a pioneer in pharmaceutical advancements since 1997, is based in San Diego, CA. Established and incorporated in California, the company operates in the Biotechnology and Pharmaceutical industries, driving innovation in drug development.

The company received its last notable investment of $22.00M during a Venture Round on 04 October 2000. This round was backed by a strong cohort of investors, including InterWest Partners, The Walden Group, Pacific Venture Group, A. M. Pappas & Associates, Koffler Group, U.S. Bancorp, Mayfield Fund, Enterprise Partners, GeneChem, and Cooper Hill Partners.

For investors, Elitra Pharmaceuticals represents an opportunity to support a stable and experienced player within a high-growth sector, with a legacy of more than two decades in the pharmaceutical landscape.

Business keywords: Pharmaceutical Preparations, Pharmaceutical Advancements, Drug Development, Pioneering Pharmaceuticals, San Diego Biotech, California Pharmaceutical Company, Private Pharmaceutical Firm, Incorporated in California, Pharmaceutical Research, Biopharmaceuticals

Services & Products

translation
interpretation

Target Customers

businesses corporations multinational companies individuals requiring professional translation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $22.00M 10
InterWest Partners The Walden Group Pacific Venture Group
InterWest Partners, The Walden Group +8
04 Oct 2000

Elitra Pharmaceuticals Alternatives & Competitors

View All Alternatives
Elitra Pharmaceuticals vs
Proprius Pharmaceuticals
Proprius Pharmaceuticals

A San Diego innovator specializing in rheumatology and autoimmune care, offering promising early-sta...

Series A
Biotechnology, Pharmaceutical
Elitra Pharmaceuticals vs
TRELYS
TRELYS

Driving innovation in biotechnology since 2012 with roots in San Francisco, California

Seed
Biotechnology, Life Sciences
Elitra Pharmaceuticals vs
ALSP, Inc.
ALSP, Inc. United States

Pioneering small molecule therapies for neurodegenerative diseases, focusing on innovative solutions...

Debt Financing
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About Elitra Pharmaceuticals

Pioneering pharmaceutical advancements since 1997, located in San Diego, CA.
Elitra Pharmaceuticals was founded in 1997.
Elitra Pharmaceuticals operates in Biotechnology and Pharmaceutical. Its work centres on Pharmaceutical Preparations, Pharmaceutical Advancements, Drug Development and Pioneering Pharmaceuticals. Its customers include businesses, corporations and multinational companies.
Elitra Pharmaceuticals has approximately 3 employees.
Elitra Pharmaceuticals has completed 1 funding round, raising a total of $22.00M. The latest funding stage is Venture round.
Elitra Pharmaceuticals offers: translation, interpretation.
Top alternatives and competitors to Elitra Pharmaceuticals include Proprius Pharmaceuticals, TRELYS, ALSP, Inc., Neurana Pharmaceuticals, ASKGENE PHARMA, INC.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Elitra Pharmaceuticals and Proprius Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Elitra Pharmaceuticals, https://bouncewatch.com/company/elitra-pharmaceuticals, updated 18 July 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout